chr6-143941682-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_001317162.2(PLAGL1):c.1134G>A(p.Leu378=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0177 in 1,614,194 control chromosomes in the GnomAD database, including 323 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.015 ( 21 hom., cov: 32)
Exomes 𝑓: 0.018 ( 302 hom. )
Consequence
PLAGL1
NM_001317162.2 synonymous
NM_001317162.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.89
Genes affected
PLAGL1 (HGNC:9046): (PLAG1 like zinc finger 1) This gene encodes a C2H2 zinc finger protein that functions as a suppressor of cell growth. This gene is often deleted or methylated and silenced in cancer cells. In addition, overexpression of this gene during fetal development is thought to be the causal factor for transient neonatal diabetes mellitus (TNDM). Alternative splicing and the use of alternative promoters results in multiple transcript variants encoding two different protein isoforms. The P1 downstream promoter of this gene is imprinted, with preferential expression from the paternal allele in many tissues. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 6-143941682-C-T is Benign according to our data. Variant chr6-143941682-C-T is described in ClinVar as [Benign]. Clinvar id is 3038305.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=2.89 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0145 (2211/152314) while in subpopulation NFE AF= 0.0221 (1501/68018). AF 95% confidence interval is 0.0211. There are 21 homozygotes in gnomad4. There are 1054 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2211 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLAGL1 | NM_001317162.2 | c.1134G>A | p.Leu378= | synonymous_variant | 8/8 | ENST00000674357.1 | NP_001304091.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLAGL1 | ENST00000674357.1 | c.1134G>A | p.Leu378= | synonymous_variant | 8/8 | NM_001317162.2 | ENSP00000501459 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0146 AC: 2215AN: 152196Hom.: 21 Cov.: 32
GnomAD3 genomes
AF:
AC:
2215
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0153 AC: 3833AN: 250456Hom.: 45 AF XY: 0.0155 AC XY: 2105AN XY: 135526
GnomAD3 exomes
AF:
AC:
3833
AN:
250456
Hom.:
AF XY:
AC XY:
2105
AN XY:
135526
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0181 AC: 26427AN: 1461880Hom.: 302 Cov.: 32 AF XY: 0.0180 AC XY: 13083AN XY: 727244
GnomAD4 exome
AF:
AC:
26427
AN:
1461880
Hom.:
Cov.:
32
AF XY:
AC XY:
13083
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0145 AC: 2211AN: 152314Hom.: 21 Cov.: 32 AF XY: 0.0142 AC XY: 1054AN XY: 74476
GnomAD4 genome
AF:
AC:
2211
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
1054
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PLAGL1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at